The Optimization of Mycoplasm Pneumonia Antibiotic Therapy
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Mycoplasma pneumoniae, an important pathogen of community acquired pneumonia,are becoming
more and more resistant to macrolide. The study aim is to optimize anti-infection therapy.